Brunei vs Italy: Cause of death, by non-communicable diseases, ages 15-59, male
Brunei
75.5%
in 2021
Italy
75.0%
in 2021
Brunei rank
11th
Italy rank
13th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Brunei
- Italy
How they compare
Brunei currently reports 75.5% against 75.0% in Italy, a difference of 0.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Italy ahead.
Brunei ranks 11th and Italy ranks 13th of 185 countries.
Across the 3 decades both report, Brunei averaged higher in 1 and Italy in 2.
Head to head by decade
| Decade | Brunei | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 59.4% | 74.9% | 15.5% | Italy |
| 2010s | 73.3% | 78.1% | 4.8% | Italy |
| 2020s | 76.5% | 74.5% | 2.0% | Brunei |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Brunei or Italy?
- Brunei, at 75.5% against 75.0% in Italy as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Brunei and Italy?
- 0.5%, with Brunei ahead.
- How many years of comparable data are there for Brunei and Italy?
- 6 years are reported by both, from 2000 to 2021.
- How do Brunei and Italy rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Brunei ranks 11th and Italy ranks 13th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.